Automated local literature monitoring helps pharma companies ensure compliance, detect safety signals early, and manage global risks efficiently through AI-driven, multilingual, and scalable surveillance solutions.

AI-driven case intake is revolutionizing pharmacovigilance by automating data capture, improving accuracy, ensuring compliance, and reducing manual workload—advancing drug safety and operational efficiency.